F.D.A. Approves Pfizer’s R.S.V. Vaccine for Older Adults

Why It Matters: Older adults are at a higher risk.

Each year, about 60,000 adults 65 and older are hospitalized with R.S.V. and about 6,000 to 10,000 die from the virus, the F.D.A.

d. The Centers for Disease Control and Prevention estimated that in one year, more than 21,000 people in that age group would need to take the GSK vaccine to prevent one R.S.V. death; the number was nearly 25,000 for the Pfizer shot.

The virus was a key…